Voltage Security, Inc., an enterprise security company, is the
global leader in information encryption. Voltage solutions, based on
next generation cryptography, provide encryption that just works
for protecting valuable, regulated and sensitive information
persistently and based on policy. Voltage delivers power, simplicity
and the lowest total cost of ownership in the industry through the use
of award-winning Voltage Identity-Based E...
more
Voltage Security, Inc., an enterprise security company, is the
global leader in information encryption. Voltage solutions, based on
next generation cryptography, provide encryption that just works
for protecting valuable, regulated and sensitive information
persistently and based on policy. Voltage delivers power, simplicity
and the lowest total cost of ownership in the industry through the use
of award-winning Voltage Identity-Based Encryption™ (IBE). Voltage
Security offerings include Voltage SecureMail™, the Voltage Data
Protection System™ and the Voltage Security Network™ (VSN), a Software
as a Service (SaaS) solution for the extended business network.
Voltage
Security is the number one OEM provider of email encryption technology
in the world with OEMs that include Microsoft, Proofpoint, Secure
Computing, Sendmail, Canon, Code Green Networks and NTT Communications.
Voltage Security partners with leading global technology companies
including: IBM, Microsoft, RIM, Symantec and others. Customers include
nearly one million licensed and deployed users at Global 1000 companies
in banking, retail, insurance, energy, healthcare and government, such
as American Board of Family Medicine, Diebold, Integro Financial, NTT
Communications, SafeAuto Insurance, Winterthur Life UK Ltd. and XL
Global Services.
Voltage delivers power, simplicity
and the lowest total cost of ownership in the industry through the use
of award-winning Voltage Identity-Based Encryption™ (IBE). Voltage
provides solutions for secure communication and data at rest to leading
financial services, healthcare, government and pharmaceutical companies.
